Statera Biopharma, Inc. to Participate in the Benzinga Healthcare Small Cap Conference20210922113736
Statera Biopharma, Inc. to Participate in the Cantor Virtual Global Healthcare Conference20210921113126
Statera BioPharma, Inc. to Ring Nasdaq Stock Market Closing Bell20210902112514
Statera BioPharma, Inc. to Ring Nasdaq Stock Market Closing Bell
September 2, 2021
Statera BioPharma, Inc. Provides Update on Integration of ImQuest20210901092000
Statera BioPharma, Inc. Provides Update on Integration of ImQuest
September 1, 2021
Cytocom, Inc. Announces Plan to Adopt New Corporate Name “Statera BioPharma, Inc.”20210831073200
Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast20210816103400
Cytocom, Inc. Reports Second Quarter 2021 Financial Results20210816073000
Cytocom, Inc. Reports Second Quarter 2021 Financial Results
August 16, 2021
Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement20210813193640
Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement20210812160500
Cytocom, Inc. Announces Participation at Liberty University’s Empowering the Kingdom Through Business Conference20210811073000